Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph Lewis currently holds 52,771 shares of Odonate Therapeutics, Inc. (ODT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Lewis has been a net seller of ODT stock. They have purchased $48.9M and sold $158.1M worth of shares.
Joseph Lewis's most recent insider trade was on Sep 12, 2025, when they sold 9,427 shares at $0.00 per share.
Joseph Lewis serves as Executive at Odonate Therapeutics, Inc. (ODT). They have executed 64 insider transactions totaling $207.1M over their tenure at the company.
Joseph Lewis holds the position of Executive at Odonate Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Joseph Lewis has shown a selling trading pattern, with $48.9M in total purchases and $158.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph Lewis was on Mar 5, 2021, when they sold $65.8M worth of MRTX shares. This transaction involved 363,000 shares at $181.15 per share.
Joseph Lewis currently owns 52,771 shares of Odonate Therapeutics, Inc. (ODT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph Lewis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph Lewis has 64 Form 4 filings on record as an insider at Odonate Therapeutics, Inc..
Set alerts for Joseph Lewis and 40,000+ other insiders.